Gates Foundation announces investments to advance mRNA vaccine research and manufacturing

At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale.

Sangamo signs agreement with Prevail to study AAV capsids

Prevail will perform in vitro and in vivo studies on some of the adeno-associated virus capsids of Sangamo. Credit: Kateryna Kon/Shutterstock.com. Sangamo Therapeutics has signed

July 18, 2023

All the new drugs approved in 2023: Alzheimer’s and gene therapy cap a five-year high

After kicking off 2023 with a potential megablockbuster in Eisai and Biogen’s new Alzheimer’s drug Leqembi, in totality the FDA signed off on 10 more

January 4, 2024

Experts release revised lung cancer testing guidelines

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) announced today

August 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.